FDA issues draft guidance on developing migraine prevention drugs
Regulatory NewsJoanne S. Eglovitch
Clinical TrialsNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchClinical TrialsNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy